Anti-Aging & Longevity

Tesamorelin: The Peptide for Visceral Fat Reduction — Evidence and Use

Tesamorelin: The Peptide for Visceral Fat Reduction — Evidence and Use

An honest medical review of Tesamorelin (Egrifta): GHRH mechanism, clinical evidence for visceral fat, dosing, contraindications, and COFEPRIS regulation.

May 18, 2026·7 min read·By Dr. Marian Tufano

Read full article: Tesamorelin: The Peptide for Visceral Fat Reduction — Evidence and Use →

Sermorelin: The Classic GHRH Peptide — Protocol and Evidence

Anti-Aging & Longevity

Sermorelin: The Classic GHRH Peptide — Protocol and Evidence

An honest medical review of Sermorelin: GHRH 1-29 analog, clinical evidence, typical dosing, comparison with CJC-1295, and COFEPRIS regulation in Mexico.

May 18, 2026·9 min read·By Dr. Marian Tufano

Read full article: Sermorelin: The Classic GHRH Peptide — Protocol and Evidence →

CJC-1295 + Ipamorelin: Protocol and Evidence in Regenerative Medicine

Anti-Aging & Longevity

CJC-1295 + Ipamorelin: Protocol and Evidence in Regenerative Medicine

What CJC-1295 and Ipamorelin are, how the GH secretagogue stack works, clinical evidence, typical dosing, and COFEPRIS regulatory context.

May 18, 2026·9 min read·By Dr. Marian Tufano

Read full article: CJC-1295 + Ipamorelin: Protocol and Evidence in Regenerative Medicine →

AOD-9604: The Fat-Loss Peptide — Does It Really Work?

Anti-Aging & Longevity

AOD-9604: The Fat-Loss Peptide — Does It Really Work?

An honest medical review of AOD-9604 (hGH 176-191 fragment): mechanism, limited clinical evidence, typical dosing, and COFEPRIS regulation in Mexico.

May 18, 2026·6 min read·By Dr. Marian Tufano

Read full article: AOD-9604: The Fat-Loss Peptide — Does It Really Work? →

Cargando…